Rani Therapeutics Holdings, Inc. (RANI) Tops Q1 EPS by 15c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q1 EPS of ($0.33), $0.15 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• Wall Street's new pair trade: Long software, short chips
• MaxLinear (MXL) Reiterated at Buy by StoneX on Earnings Growth Potential
• H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)